M&A Deal Summary

Danaher Acquires Precision NanoSystems

On June 1, 2021, Danaher acquired life science company Precision NanoSystems from Telegraph Hill Partners

Acquisition Highlights
  • This is Danaher’s 6th transaction in the Life Science sector.
  • This is Danaher’s 2nd transaction in Canada.
  • This is Danaher’s 1st transaction in British Columbia.

M&A Deal Summary

Date 2021-06-01
Target Precision NanoSystems
Sector Life Science
Buyer(s) Danaher
Sellers(s) Telegraph Hill Partners
Deal Type Add-on Acquisition

Target

Precision NanoSystems

Vancouver, British Columbia, Canada
Precision NanoSystems provides instruments, reagents, and services to life sciences researchers, including pharmaceutical companies, and builds strategic collaborations to revolutionize healthcare through nanotechnology. Precision NanoSystems was founded in 2010 and is based in Vancouver, British Columbia.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Danaher

Washington, District of Columbia, United States

Category Company
Founded 1969
Sector Diversified
Employees79,000
Revenue 23.9B USD (2023)
DESCRIPTION

Danaher designs, manufactures and markets professional, medical, industrial and commercial products and services. Danaher's research and development, manufacturing, sales, distribution, service and administrative facilities are located in more than 50 countries. Danaher's business consists of five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental; and Industrial Technologies. Danaher was incorporated in 1969 and is based in Washington, District of Columbia.


DEAL STATS #
Overall 40 of 43
Sector (Life Science) 6 of 9
Type (Add-on Acquisition) 36 of 39
State (British Columbia) 1 of 1
Country (Canada) 2 of 2
Year (2021) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-10-21 Danaher - Life Science Portfolio

Washington, District of Columbia, United States

Danaher Corp's Life Science Portfolio includes chromatography and SoloHill business. The chromatography business addresses an essential step in downstream bioprocessing and encompasses multi-use and single-use equipment as well as columns and resins. The SoloHill business includes mainly a microcarrier technology and particle validation standards used in cell culture and other bioprocesses.

Sell $750M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-06-17 Aldevron

Fargo, North Dakota, United States

Aldevron serves the biotechnology industry with the custom production of nucleic acids, proteins, and antibodies. Thousands of clients use Aldevron-produced plasmids, RNA, and gene editing enzymes for projects ranging from discovery research to clinical trials to commercial applications. These products are critical raw materials and key components in commercially available drugs and medical devices. Aldevron was founded in 1998 and is based in Fargo, North Dakota.

Buy $9.6B

Seller(S) 1

SELLER

Telegraph Hill Partners

San Francisco, California, United States

Investor Investor Investor Investor Investor


Category Venture Capital Firm
Founded 2001
Size Middle-Market
Type Sector Focused
DESCRIPTION

Telegraph Hill Partners is a specialist private equity firm focused on investing in later-stage life science, medical device, and healthcare companies. Prospective companies should be at or near profitability and demonstrate success. Other areas of interest within the healthcare sector include life science technologies, chemistry/reagent suppliers, and information management. Telegraph Hill Partners was formed in 2001 and is based in San Francisco, California.


DEAL STATS #
Overall 23 of 28
Sector (Life Science) 9 of 12
Type (Add-on Acquisition) 19 of 23
State (British Columbia) 1 of 1
Country (Canada) 1 of 1
Year (2021) 3 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-15 Akoya Biosciences

Marlborough, Massachusetts, United States

Akoya Biosciences is a developer of technologies for life science researchers to enable spatially-resolved, quantitative tissue phenotyping at the cellular and subcellular level. The combined technologies of Phenoptics and CODEX are fueling advances in next-generation tissue analysis by providing comprehensive solutions including instrumentation, reagents, and software. Akoya Biosciences was founded in 2015 and is based in Marlborough, Massachusetts.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-06-25 Teknova

Hollister, California, United States

Teknova is a manufacturer and sells cell culture media and buffers into the research and bioproduction markets. Teknova is based in Hollister, California.

Sell -